GLP-1 Receptor Agonists
US$ 22.86
10 weeks on tirzepatide Treatment comparison of 5, and 15 mg versus insulin GLP-1 Weight Loss – New
Description
View Third-Party Tests from Our Partners
Sematide Injection Higher-dose injectable for advanced management
Retatrutide's Phase 3 clinical trial data shows 28.7% average body weight reduction over 96 weeks surpassing tirzepatide and semaglutide
ChewSmart GLP-1 Patches Craving Control, Made Effortless Steady-release patches to support appetite regulation, energy, and weight balancenaturally and without pills
PlexusDx explains the risks, clinical evidence, and why a single-agent GLP-1 approach may be safer and more effective for your goals
